PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2016.0762017491274-278Human Herpesvirus 8–Unrelated Primary Effusion Lymphoma–Like Lymphoma in an Elderly Korean Patient with a Good Response to Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and PrednisoloneJunghoon Shin, Jeong-Ok Lee, Ji-Young Choe, Soo-Mee Bang, Jong-Seok Leehttp://e-crt.org/upload/pdf/crt-2016-076.pdf, http://e-crt.org/journal/view.php?doi=10.4143/crt.2016.076, http://www.e-crt.org/upload/pdf/crt-2016-076.pdf
Hematology10.1080/10245332.2018.1509461201824152-59Efficacy and tolerability of rituximab and reduced-dose cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy for elderly patient with diffuse large B-cell lymphomaKensuke Kayamori, Katsuhiro Shono, Masahiro Onoda, Akira Yokotahttps://tandfonline.com/doi/pdf/10.1080/10245332.2018.1509461, https://www.tandfonline.com/doi/pdf/10.1080/10245332.2018.1509461
Cancer10.1002/cncr.20956200510381644-1651Cost utility in the United States of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone for the treatment of elderly patients with diffuse large B-cell lymphomaJohn C. Hornberger, Jennie H. Besthttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcncr.20956, https://onlinelibrary.wiley.com/doi/full/10.1002/cncr.20956
European Journal of Cancer10.1016/j.ejca.2016.02.004201658112-121Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphomaMichael A. Fridrik, Ulrich Jaeger, Andreas Petzer, Wolfgang Willenbacher, Felix Keil, Alois Lang, Johannes Andel, Sonja Burgstaller, Otto Krieger, Willi Oberaigner, Kurt Sihorsch, Richard Greilhttps://api.elsevier.com/content/article/PII:S0959804916000885?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0959804916000885?httpAccept=text/plain
Blood Research10.5045/br.2013.48.4.2962013484296Primary diffuse large B-cell lymphoma of the bone marrow in a frail and elderly patient successfully treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisonePasquale Niscola, Massimiliano Palombi, Stefano Fratoni, Alessio Perrotti, Paolo de Fabritiishttps://synapse.koreamed.org/DOIx.php?id=10.5045/br.2013.48.4.296, https://synapse.koreamed.org/pdf/10.5045/br.2013.48.4.296, http://synapse.koreamed.org/DOIx.php?id=10.5045/br.2013.48.4.296
Chest10.1378/chest.198015520141464478AHuman Herpes Virus 8 - Unrelated Primary Effusion Lymphoma-Like Lymphoma: Classification, Diagnosis, and ManagementJatan Shah, Natasha Bhimani, Rachel Must-Ettinger, He Zhanghttps://api.elsevier.com/content/article/PII:S0012369216497369?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0012369216497369?httpAccept=text/plain
Journal of the Korean Ophthalmological Society10.3341/jkos.2013.54.8.115720135481157The Effect of Rituximab, Cyclophosphamide, Vincristine, and Prednisolone (R-CVP) Chemotherapy in Patients with Ocular Adnexal Extranodal Marginal Zone B Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue (MALT) LymphomaSung Jin Park, Won Sik Lee, Jae Wook Yanghttps://synapse.koreamed.org/DOIx.php?id=10.3341/jkos.2013.54.8.1157, https://synapse.koreamed.org/pdf/10.3341/jkos.2013.54.8.1157, http://synapse.koreamed.org/DOIx.php?id=10.3341/jkos.2013.54.8.1157
Thyroid10.1089/thy.2009.04402010204425-427Rituximab Plus Dose–Reduced Cyclophosphamide, Mitoxantrone, Vincristine, and Prednisolone Are Effective in Elderly Patients with Diffuse Large B-Cell Lymphoma of the ThyroidConstanze Jonak, Marlene Troch, Leonhard Müllauer, Bruno Niederle, Martha Hoffmann, Markus Radererhttps://www.liebertpub.com/doi/full-xml/10.1089/thy.2009.0440, https://www.liebertpub.com/doi/pdf/10.1089/thy.2009.0440
Clinical Lymphoma and Myeloma10.3816/clm.2008.n.042200885300-304A Case of HIV-Negative Primary Effusion Lymphoma Treated with Bortezomib, Pegylated Liposomal Doxorubicin, and RituximabTanya Siddiqi, Robin M. Joycehttps://api.elsevier.com/content/article/PII:S1557919011702530?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1557919011702530?httpAccept=text/plain
Cancer10.1002/cncr.266572011118133446-3446Erratum: Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphomahttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcncr.26657, http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.26657/fullpdf